← Back to Search

Behavioural Intervention

tDCS for Autism

N/A

Recruiting

Led By Peter Tsai, MD, PhD

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up post treatment (approx at 3 month)

Awards & highlights

Study Summary

This trial looks at how electric current to the brain can help improve symptoms of Autism in children.

Who is the study for?

This trial is for children and young adults aged 5 to 21 with a clinical diagnosis of Autism Spectrum Disorder (ASD). It's not suitable for those who are pregnant, have brain implants or pacemakers, any metal implants, hearing or visual impairments, a history of brain injury, or known brain/skull abnormalities unrelated to ASD.Check my eligibility

What is being tested?

The study is examining the impact of transcranial direct current stimulation (tDCS) on challenges associated with ASD. Participants will receive either the actual tDCS treatment or a sham (placebo-like) procedure to compare effects.See study design

What are the potential side effects?

Potential side effects from tDCS may include discomfort at the electrode sites on the head, itching, tingling sensations during application, headache after treatment sessions, and fatigue.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ post treatment (approx at 3 month)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~post treatment (approx at 3 month)

This trial's timeline: 3 weeks for screening, Varies for treatment, and post treatment (approx at 3 month) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Neurophysiological impacts as measured by Magnetoencephalography (MEG)

Neurophysiological impacts as measured by functional magnetic resonance imaging (fMRI)

Sensorimotor behavior as measured by Grip Strength

+4 more

Secondary outcome measures

Executive functioning as measured by Dimensional Card Change Sort

Executive functioning as measured by Flanker Inhibitory Control and Attention

Working memory as measured by Stanford Binet-V Working Memory Subtest

Trial Design

2Treatment groups

Experimental Treatment

Group I: transcranial direct current stimulation (tDCS), then sham stimulationExperimental Treatment2 Interventions

Participants receives three weeks of 20-minute tDCS stimulation. After a washout period of 3 months, they then receive three weeks of sham stimulation

Group II: Sham stimulation, then transcranial direct current stimulation (tDCS)Experimental Treatment2 Interventions

Participants receives three weeks of sham stimulation. After a washout period of 3 months, they then receive three weeks of 20-minute tDCS stimulation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Sham

2013

Completed Phase 3

~2060

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,053,675 Total Patients Enrolled

1 Trials studying Autism Spectrum Disorder

60 Patients Enrolled for Autism Spectrum Disorder

Peter Tsai, MD, PhDPrincipal InvestigatorUT Southwestern Medical Center

1 Previous Clinical Trials

60 Total Patients Enrolled

1 Trials studying Autism Spectrum Disorder

60 Patients Enrolled for Autism Spectrum Disorder

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this trial cater to individuals over 25 years of age?

"This study seeks participants aged 5 to 21 years old."

Answered by AI

Who qualifies as an appropriate candidate for this research undertaking?

"The scope of this study requires 60 autism spectrum disorder (ASD) patients aged between 5 and 21 years. To be eligible, individuals must possess a confirmed ASD diagnosis from a medical practitioner and can identify as male or female."

Answered by AI

How many participants comprise this research endeavor?

"Indeed, the records on clinicaltrials.gov corroborate that this trial is in its recruitment phase. It was first posted on June 20th of 2021 and updated as recently as October 18th. The research team needs to find 60 participants from one medical centre for the experiment to be executed successfully."

Answered by AI

Are there still vacancies available in this clinical experiment?

"Indeed, the patient recruitment process for this clinical trial is ongoing. The original listing of the study was published on June 20th 2023 and last edited on October 18th of that same year."

Answered by AI

Who else is applying?

What site did they apply to?

UT Southwestern Medical Center

What portion of applicants met pre-screening criteria?

Met criteria

Why did patients apply to this trial?

We've tried NAET and supplements recommended by my son's pediatrician. He's done Occupational, and is currently doing Speech and ABA therapy. They've helped a little, but he still struggles socially, with his behavior, and with hyperactivity.

PatientReceived 1 prior treatment

Recent research and studies

clinicaltrials.govStudy

Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project

Peter Tsai 2023. "Cerebellar Transcranial Direct Current Stimulation (tDCS) in Children With Autism Spectrum Disorder: Raynor Cerebellum Project". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05691283.

All > Autism Dallas > Tdcs